Guidelines

Revision as of 08:28, 9 December 2021 by Urology4all (talk | contribs) (Created page with "== AUA == === Oncology === ==== Prostate ==== * Advanced Prostate Cancer (2020) * Adjuvant and Salvage Radiotherapy After Prostatectomy (2019) * Prostate Cancer Screening (2018) * Clinically Localized Prostate Cancer (2017) ==== Bladder ==== * Microscopic Hematuria (2020) * Muscle-invasive Bladder Cancer (2017) * Non-muscle Invasive Bladder Cancer (2016) ==== Kidney ==== * Renal Mass and Localized Renal Cancer (2021) ==== Testicular ==== * (2019) Included in Tes...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

AUA

Oncology

Prostate

  • Advanced Prostate Cancer (2020)
  • Adjuvant and Salvage Radiotherapy After Prostatectomy (2019)
  • Prostate Cancer Screening (2018)
  • Clinically Localized Prostate Cancer (2017)

Bladder

  • Microscopic Hematuria (2020)
  • Muscle-invasive Bladder Cancer (2017)
  • Non-muscle Invasive Bladder Cancer (2016)

Kidney

  • Renal Mass and Localized Renal Cancer (2021)

Testicular

  • (2019) Included in Testicular Tumours Chapter Notes

Non-oncology

Andrology

  • Testosterone Deficiency (2018)
  • Erectile Dysfunction (2018)
  • Peyronie's Disease (2015)

Functional

  • Surgical Management BPH (2018)
  • AUA/CUA Mesh Position Statement (2019)
  • Incontinence after Prostate Therapy (2019)
  • Female SUI (2017)

Infections and Inflammation

  • AUA/CUA Recurrent UTI (2019)
  • Pediatrics Vesicoureteral Reflux (2017)

Stones

  • Evaluation and Medical Management of Stones (2019)
  • Stone Surgery (2016)

Other

  • Urotrauma (2020)
  • Male Urethral Stricture (2016)
  • Vasectomy (2015)

Contribute

  • BPH (2021)
  • Infertility (2021)
  • Priapism (2021)
  • OAB (2019)
  • Antibiotic Prophylaxis (2019)

CUA

Oncology

Prostate Castrate-resistant Prostate Cancer (2021)

Androgen Deprivation Therapy: Adverse Events & Management (2021)

Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)

Testosterone Suppression (2018)

Prostate Cancer Screening (2017)

Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)

Prostate Cancer Active Surveillance (2015)

Bladder Non-muscle Invasive Bladder Cancer (2021)

Advanced and Metastatic Urothelial Cancer (2019)

Muscle-invasive Bladder Cancer (2019)

Asymptomatic Mircoscopic Hematuria (2008)

Kidney Follow-up Localized RCC (2018)

Cystic Renal Lesions (2017)

Small Renal Masses (2015)

Surgical Management of RCC (2014)

RCC Genetic Screening (2013)

Non-oncology

Andrology Peyronie's Disease (2018)

Erectile Dysfunction (2021)

Functional Neurogenic Lower Urinary Tract Dysfunction (2019)

Male LUTS/BPH (2018)

CUA/AUA Mesh Position Statement (2019)

Overactive Bladder (2017)

Infections and Inflammation CUA/AUA Recurrent UTI (2019)

Antibiotic Prophylaxis (2015)

Chronic Scrotal Pain (2018)

Interstitial Cystitis (2016)

Infertility Azoospermia (2015)

Pediatrics Circumcision (2018)

Antenatal hydronephrosis (2017)

Cryptorchidism (2017)

Multicystic Dysplastic Kidney in the Neonate (2015)

Stones Evaluation and Medical Management of Stones (2016)

Ureteral Calculi (2015)

Other Vasectomy (2016)

Adrenal Mass (2011)

Radiation-induced Hemorrhagic Cystitis (2018)

VTE Prophylaxis (2019)

Contribute

Ureteral calculi (2022)

Pediatric bladder dysfunction (2021)

Sporadic angiomyolipomas (2020)

Male urethral stricture (2020)

Catheter use (2020)

Renal mass biopsy (2019)

Pheochromocytoma surveillance (2019)

Pediatric hemorrhagic cystitis (2019)